Finance

Lists
6185:HKG
Cansino Biologics Inc
30,32 HKD
+1,68%
(+0,50) 1D
16-окт., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 6185...
Open
30,88 HKD
High
32,64 HKD
Low
29,92 HKD
Mkt. cap
14,45 млд
Avg. vol.
5,69 млн
Volume
6,41 млн
P/E ratio
157,20
52-wk high
47,80 HKD
52-wk low
19,22 HKD
EPS
0,19 HKD
No. of employees
1 миң
Open
30,88 HKD
High
32,64 HKD
Low
29,92 HKD
Mkt. cap
14,45 млд
Avg. vol.
5,69 млн
Volume
6,41 млн
P/E ratio
157,20
52-wk high
47,80 HKD
52-wk low
19,22 HKD
EPS
0,19 HKD
No. of employees
1 миң
News stories
From web sources and news partners
Profile
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
About Cansino Biologics Inc
CEOXuefeng Yu
Employees1,18 миң
Founded2009-ж., 13-янв.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
310,24 млн
375,34 млн
190,28 млн
359,54 млн
Cost of goods sold
55,37 млн
129,82 млн
36,26 млн
97,60 млн
Cost of revenue
55,37 млн
129,82 млн
36,26 млн
97,60 млн
Research and development expenses
76,87 млн
88,37 млн
71,41 млн
84,08 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
158,60 млн
187,81 млн
116,85 млн
158,72 млн
Operating expense
218,49 млн
325,84 млн
182,92 млн
258,68 млн
Total operating expenses
273,86 млн
455,66 млн
219,19 млн
356,28 млн
Operating income
36,38 млн
-80,32 млн
-28,90 млн
3,26 млн
Other non operating income
-8,06 млн
5,34 млн
-9,91 млн
7,97 млн
EBT including unusual items
27,79 млн
13,25 млн
-34,38 млн
40,42 млн
EBT excluding unusual items
40,15 млн
-74,47 млн
-36,57 млн
-3,72 млн
Income tax expense
-134,75 миң
-181,72 миң
6,04 млн
714,36 миң
Effective tax rate
-0,48%
-1,37%
-17,58%
1,77%
Other operating expenses
-15,79 млн
50,87 млн
-9,21 млн
12,43 млн
Net income
27,93 млн
13,43 млн
-40,42 млн
39,70 млн
Net profit margin
9,00%
3,58%
-21,24%
11,04%
Earnings per share
-
-
-
-
Interest and investment income
13,97 млн
21,09 млн
9,43 млн
12,84 млн
Interest expense
-11,11 млн
-3,20 млн
-7,19 млн
-5,91 млн
Net interest expenses
2,86 млн
17,88 млн
2,24 млн
6,92 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
82,74 млн
-39,25 млн
12,18 млн
49,79 млн
Gain or loss from assets sale
84,72 миң
-137,05 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору